|
| |
NexBio Incorporated Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - NexBio Incorporated
NexBio Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/27147-NexBio_Incorp...
|
BioSpace - NexBio, Inc. News, Search Jobs, Events
8 Nov 2005 ... NexBio, Inc. Receives A $6 Million National Institutes of Health (NIH) SBIR Grant For The Clinical Development Of A Novel Influenza Medicine ...
http://www.biospace.com/company_profile.aspx?CompanyId=69772...
|
BioPortfolio - NexBio Incorporated - Profile
View the current NexBio Incorporated Page on BioPortfolio.com ... NexBio, Inc., 6650 Lusk Boulevard, Suite B102, San Diego, CA 92121, USA. ...
http://www.bioportfolio.com/biocorporate/27147-NexBio+Incorp...
|
Director/Sr. Director, Clinical Research Job, NexBio, Inc., San ...
28 Jul 2008 ... NexBio Inc. (www.nexbio.com) is a fast growing biopharmaceutical company that is dedicated to create and develop novel broad-spectrum ...
http://www.biospace.com/job_view.aspx?JOB_ID=244075...
|
NEXBIO, INC. All NIH Grants for FY 2006 ...
NEXBIO, INC. | . R44AI056786-04 | . Yu, Mang | . Development of Fludase for Prevention of Influenza | . | . | ...
http://report.nih.gov/award/trends/InstInfoExcel.cfm?OrgID=1...
Fish & Richardson P.C. - About Us
NexBio, Inc. NHL Enterprises, L.P. Nokia Corporation Nventa Biopharmaceuticals Corporation Ocean Spray Cranberries, Inc. OmniGuide Communications ...
http://www.fr.com/about/clientlist.cfm...
|
NEXBIO, INC. All NIH Grants for FY 2005 ...
NEXBIO, INC. | . R43AI060188-02 | . Fang, Fang | . A Novel Therapeutics for Pandemic & Epidemic Flu | . | . | ...
http://report.nih.gov/award/trends/InstInfoExcel.cfm?OrgID=1...
BioPortfolio - Biocorporate Search AL
NexBio Incorporated. In recent years the world has witnessed the outbreak of SARS, the worldwide spread of avian influenza viruses, and the escalating ...
http://www.bioportfolio.com/biocorporate/search/region/AL.ht...
|
Non-linear enzymatic logic in natural product modular mega ...
NexBio's DAS-181: Phase I clinical trials. underway. San Diego-based NexBio Inc was founded in 2002 to discover. and develop biopharmaceuticals targeting ...
http://www.biomedcentral.com/content/pdf/cd-854583.pdf...
|
Therapeutic Awards, Biodefense, NIAID, NIH
19 Jan 2007 ... Development of DAS 181 (FludaseĀ®) as a Broad Spectrum Therapeutic Agent for All Annual and Pandemic Variations of Influenza, NexBio, Inc., ...
http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefens...
|
|
| |
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner.
|
All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited. |
|
|
|